Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.
<h4>Background</h4>Mesenchymal stromal cells (MSCs, "adult stem cells") have been widely used experimentally in a variety of clinical contexts. There is interest in using these cells in critical illness, however, the safety profile of these cells is not well known. We thus cond...
Guardado en:
Autores principales: | Manoj M Lalu, Lauralyn McIntyre, Christina Pugliese, Dean Fergusson, Brent W Winston, John C Marshall, John Granton, Duncan J Stewart, Canadian Critical Care Trials Group |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b8655dd2afe54445977d83005acb0f1c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol
por: Kelly D Cobey, et al.
Publicado: (2021) -
The cell surface proteome of human mesenchymal stromal cells.
por: Christian Niehage, et al.
Publicado: (2011) -
Pluripotency and immunomodulatory signatures of canine induced pluripotent stem cell-derived mesenchymal stromal cells are similar to harvested mesenchymal stromal cells
por: Arash Shahsavari, et al.
Publicado: (2021) -
Endothelial differentiation of mesenchymal stromal cells.
por: Karolina Janeczek Portalska, et al.
Publicado: (2012) -
Targeting Autophagy in Dendritic Cells as a Mechanism to Limit Immunopathogenesis in Herpetic Stromal Keratitis
por: John A. Blaho
Publicado: (2016)